Carcinogenic Risk Factors
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Retinoblastoma Tumor-Suppressor Gene, the Exception That Proves the Rule
Oncogene (2006) 25, 5233–5243 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc REVIEW The retinoblastoma tumor-suppressor gene, the exception that proves the rule DW Goodrich Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA The retinoblastoma tumor-suppressor gene (Rb1)is transmission of one mutationally inactivated Rb1 allele centrally important in cancer research. Mutational and loss of the remaining wild-type allele in somatic inactivation of Rb1 causes the pediatric cancer retino- retinal cells. Hence hereditary retinoblastoma typically blastoma, while deregulation ofthe pathway in which it has an earlier onset and a greater number of tumor foci functions is common in most types of human cancer. The than sporadic retinoblastoma where both Rb1 alleles Rb1-encoded protein (pRb) is well known as a general cell must be inactivated in somatic retinal cells. To this day, cycle regulator, and this activity is critical for pRb- Rb1 remains an exception among cancer-associated mediated tumor suppression. The main focus of this genes in that its mutation is apparently both necessary review, however, is on more recent evidence demonstrating and sufficient, or at least rate limiting, for the genesis of the existence ofadditional, cell type-specific pRb func- a human cancer. The simple genetics of retinoblastoma tions in cellular differentiation and survival. These has spawned the hope that a complete molecular additional functions are relevant to carcinogenesis sug- understanding of the Rb1-encoded protein (pRb) would gesting that the net effect of Rb1 loss on the behavior of lead to deeper insight into the processes of neoplastic resulting tumors is highly dependent on biological context. -
Central Nervous System Cancers Panel Members Can Be Found on Page 1151
1114 NCCN David Tran, MD, PhD; Nam Tran, MD, PhD; Frank D. Vrionis, MD, MPH, PhD; Patrick Y. Wen, MD; Central Nervous Nicole McMillian, MS; and Maria Ho, PhD System Cancers Overview In 2013, an estimated 23,130 people in the United Clinical Practice Guidelines in Oncology States will be diagnosed with primary malignant brain Louis Burt Nabors, MD; Mario Ammirati, MD, MBA; and other central nervous system (CNS) neoplasms.1 Philip J. Bierman, MD; Henry Brem, MD; Nicholas Butowski, MD; These tumors will be responsible for approximately Marc C. Chamberlain, MD; Lisa M. DeAngelis, MD; 14,080 deaths. The incidence of primary brain tumors Robert A. Fenstermaker, MD; Allan Friedman, MD; Mark R. Gilbert, MD; Deneen Hesser, MSHSA, RN, OCN; has been increasing over the past 30 years, especially in Matthias Holdhoff, MD, PhD; Larry Junck, MD; elderly persons.2 Metastatic disease to the CNS occurs Ronald Lawson, MD; Jay S. Loeffler, MD; Moshe H. Maor, MD; much more frequently, with an estimated incidence ap- Paul L. Moots, MD; Tara Morrison, MD; proximately 10 times that of primary brain tumors. An Maciej M. Mrugala, MD, PhD, MPH; Herbert B. Newton, MD; Jana Portnow, MD; Jeffrey J. Raizer, MD; Lawrence Recht, MD; estimated 20% to 40% of patients with systemic cancer Dennis C. Shrieve, MD, PhD; Allen K. Sills Jr, MD; will develop brain metastases.3 Abstract Please Note Primary and metastatic tumors of the central nervous system are The NCCN Clinical Practice Guidelines in Oncology a heterogeneous group of neoplasms with varied outcomes and (NCCN Guidelines®) are a statement of consensus of the management strategies. -
Tasmanian Devils' Transmissible Cancer
Tasmanian devils’ transmissible cancer: Izarbe Aísa Marín Genetics Bachelor’s Degree What is the future? Final Project | June 2017 Introduction Devil Facial Tumor Disease 1Why is Tasmanian devils’ cancer incidence so high? 2Introduction to transmissible cancers Carcinogenesis is thought to occur via Peto’s Paradox represents the lack of accumulation of mutations and mutation correlation between cancer prevalence rates depend on cell number, which and body size or lifespan and it can be Primary Mode of Lack of Capacity for correlates with body size and lifespan. useful to explore cases that are far tumor’s origin transmission allorecognition infinite growth Then, large and long-lived animals from what is expected. Tasmanian should have more cancers than smaller devils suffer from Devil Facial Tumor and shorter-lived ones, due to increased Disease (DFTD), a lethal transmissible The ancestral type of DTDF is thought to be derived from a Schwann cell (clonal number of cell divisions. cancer that is threatening the species origin) and it is transmitted by biting during mating or feeding interactions. to extinction. (2) (1) y = 0,0815 - 0,0061x [y=%Tumors; x=Log(Mass[x]*LifeSpan[y])] 10x DFTD was first reported in Mount William National Park, northeastern Tasmania, in 1996. In 20 years, the disease has spread to more than 85% Forestier of wild Tasmanian devil Peninsula populations, causing severe declines. Immunology of DFTD 3Why devils immune system do not recognize DFTD? (3) Deficiency of devil Marsupials’ immune system is different immune system from, rather than inferior to mammals’ immune system. Immunological Low genetic Slower immune responses tolerance diversity facilitate early transmission events. -
Chemical, Biological, and Environmental Factors Responsible for The
CHEMICAL, BIOLOGICAL, AND ENVIRONMENTAL FACTORS RESPONSIBLE FOR THE - -v - - - IN THE AUBURN CITY WATER SUPPLY AGRICULTURAL EXPERIMENT STATION/AUBURN UNIVERSITY R. DENNIS ROUSE, DIRECTOR AUBURN, ALABAMA BULLETIN 490 JULY 1977 CONTENTS Page INTRODUCTION ........ .. .. ............... 3 Background on Odors of Biological Origin in Water .......................... 3 Odor in the Auburn Water ........................... 5 PROCEDURES ............................ 5 RESULTS AND DISCUSSION ........... ...... .......... 7 Biological Factors................................ 7 Chemical Factors ............................... 22 Environmental Factors Related to the Growth and Production of Odorous Substances by Actinomycetes ....... 24 Correlation of Rainfall, Temperature, and Threshold Odor Number (TON) ................... 39 SUMMARY ... ... ...................... ........... 41 REFERENCES ................... ....... ... .......... 45 FIRST PRINTING 3M, JULY 1977 ACKNOWLEDGEMENTS The authors wish to thank the Auburn Water Board for the financial support of this project, the Auburn Water Treatment Plant for supplying TON values, Dr. John Lawrence for use of the carbon analyzer, and Sandy Williams, Frank Seesock, and Susan Brownlee for technical assistance. Information contained herein is available to all without regard to race, color, or nationalorigin. CHEMICAL, BIOLOGICAL, and ENVIRONMENTAL FACTORS RESPONSIBLE for the EARTHY ODOR in the AUBURN CITY WATER SUPPLY J. D. WEETE, W. T. BLEVINS, G. R.WILT, and D. DURHAM' INTRODUCTION Background On Odors Of Biological Origin in Water HE OCCURRENCE of objectionable odors in water used for drinking and commercial purposes is well documented in certain regions of the United States (1, 4, 12, 15) and various other parts of the world. (1, 8, 9, 11). Odors in sur- face waters may originate from industrial and municipal sewage effluents or from biological activities of algae or heterotrophic microorganisms. Odors of biological origin may be due to decomposition of organisms or to the produc- tion of microbial metabolites. -
Commentary: Facing the Challenge of Gene-Environment Interaction: the Two-By-Four Table and Beyond
American Journal of Epidemiology Vol. 153, No. 10 Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health Printed in U.S.A. All rights reserved The Challenge of Gene-Environment Interaction Botto and Khoury PRACTICE OF EPIDEMIOLOGY Commentary: Facing the Challenge of Gene-Environment Interaction: The Two-by-Four Table and Beyond Lorenzo D. Botto1 and Muin J. Khoury2 As a result of the Human Genome Project, epidemiologists can study thousands of genes and their interaction with the environment. The challenge is how to best present and analyze such studies of multiple genetic and environmental factors. The authors suggest emphasizing the fundamental core of gene-environment interaction—the separate assessment of the effects of individual and joint risk factors. In the simple analysis of one genotype and an exposure (both dichotomous), such study can be summarized in a two-by-four table. The advantages of such a table for data presentation and analysis are many: The table displays the data efficiently and highlights sample size issues; it allows for evaluation of the independent and joint roles of genotype and exposure on disease risk; and it emphasizes effect estimation over model testing. Researchers can easily estimate relative risks and attributable fractions and test different models of interaction. The two-by-four table is a useful tool for presenting, analyzing, and synthesizing data on gene-environment interaction. To highlight the role of gene-environment interaction in disease causation, the authors propose that the two-by-four table is the fundamental unit of epidemiologic analysis. Am J Epidemiol 2001;153:1016–20. -
Environmental Factors Affecting the Composition and Diversity of The
Imai et al. Journal of Ecology and Environment (2017) 41:8 Journal of Ecology DOI 10.1186/s41610-017-0027-2 and Environment RESEARCH Open Access Environmental factors affecting the composition and diversity of the avian community in igune, a traditional agricultural landscape in northern Japan Haruka Imai1*, Tohru Nakashizuka1,2 and Michio Oguro1,3 Abstract Background: “Igune,” a traditional agricultural landscape in the Tohoku region of Japan, is characterized by small-scale artificial woodlots surrounding a farmer’s house that are interspersed with paddy fields. During the rapid economic growth of Japan over recent decades, some igune woodlots have been abandoned or logged. Biodiversity conservation is an important issue worldwide, and traditional agricultural landscapes are of particular interest. To elucidate the role of igune landscapes in conserving biodiversity, we examined the effects of environmental factors on avian communities. Results: The study was conducted in the suburban areas of Oshu and Hanamaki cities, Iwate Prefecture, Japan, at eight sites that varied in the density and area of igune woodlots within the landscape. Bird surveys were conducted from the middle to late breeding season, and several environmental factors of the igune landscape were also measured. The results of canonical correspondence analysis indicated that the characteristics of avian communities were mainly determined by the total forested area in the landscape. Increased total forested area and shrubs layer of igune woodlots did not cause a reduction in number of bird species of any habitat and foraging types, while increased both in species number and abundance of insectivores and forest species. The number of raptor species increased in igune sites without shrubs. -
How Much Global Ill Health Is Attributable to Environmental Factors?
ORIGINAL ARTICLES How Much Global Ill Health Is Attributable to Environmental Factors? Kirk R. Smith,1 Carlos F. Corvalán2, and Tord Kjellström3 Over the years, estimates have been made of the portions of attributed to environmental risk factors. Children under 5 human mortality and morbidity that can be attributed to years of age seem to bear the largest environmental burden, environmental factors. Frustratingly, however, even for a and the portion of disease due to environmental risks seems single category of disease such as cancer, these estimates to decrease with economic development. A summary of have often varied widely. Here we attempt to explain why these estimates first appeared in the 1997 report, "Health such efforts have come to such different results in the past and Environment in Sustainable Development," which was and to provide guidance for doing such estimates more the World Health Organization's contribution to the 5-year consistently in the future to avoid the most important pitfalls. anniversary of the Rio Earth Summit. A full explanation of We do so by carefully defining what we mean by the terms how these estimates were made is first presented here. We "environmental," "ill health," and "attributable." Finally, end with a call for a program of "strategic epidemiology," based on these recommendations, we attempt our own which would be designed to fill important gaps in the estimate, appropriately qualified according to the many understanding of major environmental health risks in remaining uncertainties. Our estimate is that 25-33% of the important population groups worldwide. (Epidemiology global burden of disease can be 1999;10:573-584) Keywords: environmental exposures, morbidity, mortality, children, environmental health risks, populations, global factors, public health. -
Principles of Cancer Prevention and Will Emphasize the Scientific Underpinnings of This Emerging Discipline
Seminars in Oncology Nursing, Vol 21, No 4 (November), 2005: pp 229-235 229 OBJECTIVE: To summarize the scientific prin- ciples underlying cancer preven- tion. PRINCIPLES OF DATA SOURCES: Articles, text books, personal com- CANCER munications, and experience. CONCLUSION: PREVENTION The scientific basis of cancer pre- vention is complex and involves experimental and epidemiologic approaches and clinical trials. FRANK L. MEYSKENS,JR AND PATRICIA TULLY IMPLICATIONS FOR NURSING PRACTICE: ANCER prevention has classically encompassed As more information becomes three large areas of clinical practice: prevention, available regarding proven and screening, and early detection. Several excellent potential cancer-prevention strate- reviews and book chapters have been published gies, oncology nurses are regu- involving these topics.1-3 The importance of bio- larly called upon to guide patients Clogical and molecular markers as potential surrogates have been and others in making choices re- emphasized in the past several years,4,5 and more recently precan- garding preventative options. It is cers or intraepithelial neoplasia (IEN) have become a target.6,7 The important for oncology nurses to integration of the well-established approaches of prevention, stay abreast of this growing body screening, and early detection with biological measures of disease of knowledge. risk, progression, and prognosis has become the hallmark of mod- ern cancer prevention (see Fig 1). In this article we will review the principles of cancer prevention and will emphasize the scientific underpinnings of this emerging discipline. The principles of cancer prevention have evolved from three separate scientific disciplines: carcinogenesis, epidemiology, and clinical trials. Many other areas From the Department of Medicine and of science and medicine, including genetics and the behavioral Biological Chemistry, Chao Family Com- sciences, are contributing to this evolving and complex field. -
Inhibitors of Mammalian Target of Rapamycin Downregulate MYCN Protein Expression and Inhibit Neuroblastoma Growth in Vitro and in Vivo
Oncogene (2008) 27, 2910–2922 & 2008 Nature Publishing Group All rights reserved 0950-9232/08 $30.00 www.nature.com/onc ORIGINAL ARTICLE Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo JI Johnsen1,6, L Segerstro¨ m1,6, A Orrego2, L Elfman1, M Henriksson3,BKa˚ gedal4, S Eksborg1, B Sveinbjo¨ rnsson1,5 and P Kogner1 1Department of Woman and Child Health, Karolinska Institutet, Childhood Cancer Research Unit, Stockholm, Sweden; 2Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; 3Department of Microbiology, Tumor and Cellbiology, Karolinska Institutet, Stockholm, Sweden; 4Division of Clinical Chemistry, Faculty of Health Sciences, Linko¨ping University, Sweden and 5Department of Cell Biology and Histology, University of Tromso¨, Tromso¨, Norway Mammalian target of rapamycin (mTOR) has been shown the most common and deadly solid tumor of childhood to play an important function in cell proliferation, (Brodeur, 2003). Amplification of the MYCN oncogene metabolism and tumorigenesis, and proteins that regulate is associated with rapid tumor progression and fre- signaling through mTOR are frequently altered in human quently detected in advanced-stage neuroblastoma, but cancers. In this study we investigated the phosphorylation is also a major negative prognostic factor in localized status of key proteins in the PI3K/AKT/mTOR pathway tumors (Schwab et al., 2003). Advanced-stage tumors and the effects of the mTOR inhibitors rapamycin and and those with MYCN amplification show typically CCI-779 on neuroblastoma tumorigenesis. Significant emergence of treatment resistance, and alternative expression of activated AKT and mTOR were detected treatment strategies for these patients are therefore in all primary neuroblastoma tissue samples investigated, urgently needed. -
Public Health Classifications Project – Determinants of Health
Public Health Classifications Project – Determinants of Health Phase Two: Final Report Acknowledgements We acknowledge the National Public Health Partnership for leading the first phase of work on public health classification; the New South Wales Department of Health and the Public Health Information Development Unit, the University of Adelaide for sponsoring this Project; colleagues from both for their support of the Project Officer; the Sax Institute for providing meeting premises and equipment; and the National Centre for Classification in Health for access to ICD-10, the 11th coding conference and opportunities to meet and discuss issues with ICD coders. NSW DEPARTMENT OF HEALTH 73 Miller Street NORTH SYDNEY NSW 2060 Tel. (02) 9391 9000 Fax. (02) 9391 9101 TTY. (02) 9391 9900 www.health.nsw.gov.au Report prepared for the New South Wales Department of Health Report prepared by Su Gruszin, the Project Officer; Louisa Jorm, the Chair of the Project Working Group; and Working Group members: Tim Churches, Richard Madden, Sarah Thackway, and Ros Madden. This work is copyright. It may be reproduced in whole or in part for study training purposes subject to the inclusion of an acknowledgement of the source. It may not be reproduced for commercial usage or sale. Reproduction for purposes other than those indicated above requires written permission from the NSW Department of Health. © NSW Department of Health 2010 SHPN (CER) 100195 ISBN 978-1-74187-461-7 Further copies of this document can be downloaded from the NSW Health website www.health.nsw.gov.au December 2010 Contents Executive Summary ................................................................. 3 Section 1: Introduction ............................................................. -
1P36 Tumor Suppression—A Matter of Dosage?
Published OnlineFirst November 20, 2012; DOI: 10.1158/0008-5472.CAN-12-2230 Cancer Review Research 1p36 Tumor Suppression—A Matter of Dosage? Kai-Oliver Henrich, Manfred Schwab, and Frank Westermann Abstract A broad range of human malignancies is associated with nonrandom 1p36 deletions, suggesting the existence of tumor suppressors encoded in this region. Evidence for tumor-specific inactivation of 1p36 genes in the classic "two-hit" manner is scarce; however, many tumor suppressors do not require complete inactivation but contribute to tumorigenesis by partial impairment. We discuss recent data derived from both human tumors and functional cancer models indicating that the 1p36 genes CHD5, CAMTA1, KIF1B, CASZ1, and miR-34a contribute to cancer development when reduced in dosage by genomic copy number loss or other mechanisms. We explore potential interactions among these candidates and propose a model where heterozygous 1p36 deletion impairs oncosuppressive pathways via simultaneous downregulation of several dosage-dependent tumor suppressor genes. Cancer Res; 72(23); 1–10. Ó2012 AACR. Introduction (Fig. 1; refs. 1, 17–29). Despite extensive 1p36 candidate gene Deletions of the distal short arm of chromosome 1 (1p) are sequence analyses, success was limited for identifying tumor- fi frequently observed in a broad range of human cancers, speci c mutations in neuroblastomas or other malignancies, including breast cancer, cervical cancer, pancreatic cancer, which led some to conclude that a deletion mapping approach pheochromocytoma, thyroid cancer, hepatocellular cancer, was unlikely to deliver tumor suppressor genes. Many tumor colorectal cancer, lung cancer, glioma, meningioma, neuro- suppressor genes, however, do not require inactivation in a blastoma, melanoma, Merkel cell carcinoma, rhabdomyosar- classic "two-hit" manner but contribute to tumor development coma, acute myeloid leukemia, chronic myeloid leukemia, and when their dosage is reduced, sometimes only subtly, by non-Hodgkin lymphoma (1, 2). -
Bioactive Nutrients and Nutrigenomics in Age-Related Diseases
molecules Review Bioactive Nutrients and Nutrigenomics in Age-Related Diseases Tania Rescigno 1, Luigina Micolucci 2,3, Mario F. Tecce 1 and Anna Capasso 1,* 1 Department of Pharmacy, University of Salerno, Fisciano 84084, Italy; [email protected] (T.R.); [email protected] (M.F.T.) 2 Computational Pathology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona 60120, Italy; [email protected] 3 Laboratory of Experimental Pathology, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona 60120, Italy * Correspondence: [email protected]; Tel.: +39-089-989744 Academic Editor: Philippe Bulet Received: 18 November 2016; Accepted: 3 January 2017; Published: 8 January 2017 Abstract: The increased life expectancy and the expansion of the elderly population are stimulating research into aging. Aging may be viewed as a multifactorial process that results from the interaction of genetic and environmental factors, which include lifestyle. Human molecular processes are influenced by physiological pathways as well as exogenous factors, which include the diet. Dietary components have substantive effects on metabolic health; for instance, bioactive molecules capable of selectively modulating specific metabolic pathways affect the development/progression of cardiovascular and neoplastic disease. As bioactive nutrients are increasingly identified, their clinical and molecular chemopreventive effects are being characterized and systematic analyses encompassing the “omics” technologies (transcriptomics, proteomics and metabolomics) are being conducted to explore their action. The evolving field of molecular pathological epidemiology has unique strength to investigate the effects of dietary and lifestyle exposure on clinical outcomes. The mounting body of knowledge regarding diet-related health status and disease risk is expected to lead in the near future to the development of improved diagnostic procedures and therapeutic strategies targeting processes relevant to nutrition.